Profiling Molecular Regulators of Recurrence in Chemorefractory Triple-Negative Breast Cancers

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-019-1171-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Stratification of Triple-Negative Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2010English

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Cancer Discovery
Oncology
2013English

BRCA1/2-negative Hereditary Triple-Negative Breast Cancers Exhibit BRCAness

International Journal of Cancer
Cancer ResearchOncology
2017English

Differences in Molecular Features of Triple-Negative Breast Cancers Based on the Age at Diagnosis

Cancer
Cancer ResearchOncology
2018English

Transgelin: A Potentially Useful Diagnostic Marker Differentially Expressed in Triple-Negative and Non–triple-Negative Breast Cancers

Human Pathology
Forensic MedicinePathology
2015English

BRCA1-IRIS Inactivation Overcomes Paclitaxel Resistance in Triple Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2015English

Genetic Variations in Triple-Negative Breast Cancers Undergoing Neo-Adjuvant Chemotherapy

2019English

Molecular Stratification Within Triple-Negative Breast Cancer Subtypes

Scientific Reports
Multidisciplinary
2019English

Novel Immunohistochemistry-Based Signatures to Predict Metastatic Site of Triple-Negative Breast Cancers

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy